USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Regenerative Medicine Market
A New Era in Human Health to Resolve Unmet Medical Needs
05-May-2014
North America
Market Research
MA1E-01-00-00-00
LS00100-NA-MR_16941
$3,950.00
Special Price $2,962.50 save 25 %
This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segments—gene therapy, tissue engineering, and small molecules and biologics—has also been provided.
Executive Summary
Executive Summary (continued)
Regenerative Medicine Market—Game-changing Strategies
Methodology and Scope
Introduction
Introduction (continued)
Introduction (continued)
Market Overview—Segmentation
Market Overview—Cell Therapy (CT)Segment
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Gene Therapy (GT) Segment
Market Overview—Tissue Engineering (TE) Segment
Market Overview—Small Molecules and Biologics Segment
Cell Therapy—Competitive Landscape of Marketed Products
Cell Therapy—Competitive Landscape of Products in Development
Cell Therapy—Market Segmentation
Cell Therapy—Marketed Products Synopsis
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Product Dashboard—Apligraf (Organogenesis)
Product Dashboard—GINTUIT (Organogenesis)
Product Dashboard—Provenge (Dendreon)
Product Dashboard—Grafix (Osiris Therapeutics)
Product Dashboard—Dermagraft (Shire)
Product Dashboard—Osteocel Plus (NuVasive)
Product Dashboard—ReCell Spray-On Skin (Avita Medical)
Product Dashboard—Trinity Evolution (Orthofix)
Product Dashboard—BioDfactor (BioD, LLC)
Product Dashboard—BioDfence (BioD, LLC)
Cell Therapy—Pipeline Synopsis
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy—Pipeline Breakdown
Company—Aastrom Biosciences, Inc.
Company—Advanced Cell Technology, Inc.
Company—Aldagen, Inc. (Acquired by Cytomedix)
Company—Athersys, Inc.
Company—Celgene Cellular Therapeutics
Company—Cellerant Therapeutics, Inc.
Company—Gamida Cell Ltd.
Company—Garnet BioTherapeutics
Company—Histogenics
Company—Mesoblast Ltd.
Company—Neuralstem, Inc.
Company—Osiris Therapeutics, Inc.
Company—Pluristem Therapeutics, Inc.
Company—SanBio, Inc.
Company—StemCells, Inc.
Company—TCA Cellular Therapy, LLC
Company—TiGenix NV
Gene Therapy Overview
Gene Therapy Overview (continued)
Gene Therapy Overview (continued)
Key Company to Watch—Juventas Therapeutics Inc.
Tissue Engineering Overview
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Small Molecules and Biologics Overview
Small Molecules and Biologics Overview (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Vascular Disease Regenerative Medicine Market
Vascular Disease Regenerative Medicine Market (continued)
Non-Healing Wounds Regenerative Medicine Market
Non-Healing Wounds Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market
Spinal Cord Injury Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market (continued)
Alzheimer’s Disease Regenerative Medicine Market
Alzheimer’s Disease Regenerative Medicine Market (continued)
Parkinson’s Disease (PD) Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market (continued)
Musculoskeletal Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market
Autoimmune Disorders Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market (continued)
Stroke Regenerative Medicine Market
Stroke Regenerative Medicine Market (continued)
Diabetes Regenerative Medicine Market
Diabetes Regenerative Medicine Market (continued)
Ocular Diseases Regenerative Medicine Market
Ocular Diseases Regenerative Medicine Market (continued)
Regenerative Medicine Market—Timeline of Key Events
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Funding Scenario
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Conclusions and Recommendations
Legal Disclaimer
Human Embryonic Stem Cells Overview
Mesenchymal Stem Cells Overview
Neural Stem Cells Overview
Induced Pluripotent Stem Cells Overview
Stem Cell Types in Development
List of Abbreviations
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
05 Aug 2026 | Global | Frost Radar
Frost Radar™: Shop Floor-Centric Augmented Connected Worker Platforms, 2026
Manufacturers are confronting a skilled labor shortage. As they try to find a solution, augmented connected worker (ACW) platforms can become a key ally in training the new workforce and strengthening employee retention through comprehensive upskilling capabilities, skills management tools, and assi...
05 Aug 2026 | Global | Market Research
Material Trends and Dynamics in Battery Recycling, 2025–2032
Frost & Sullivan analyzes the global battery recycling market, focusing on the evolving lithium-ion battery (LIB) ecosystem.
The study explores the trends and dynamics shaping the battery recycling value chain, from battery production and usage to collection, pre-processing, material recovery...
04 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Enhanced Advanced Driver Assistance Systems, 2026
This Frost Radar examines advanced driver assistance systems (ADAS), ADAS AI, and next-stage autonomous-driving technologies as a fast-evolving domain reshaping mobility and safety. As automakers, Tier I suppliers, chipmakers, AI software developers, and autonomous mobility companies improve percept...
04 Aug 2026 | Global | Customer Research
Voice of Customer Network & Wireless Services Survey, Global, 2026
This Frost & Sullivan 2026 Voice of the Customer survey analyzes enterprise network priorities and the growing role of NaaS across a global sample of 1,200+ IT decision-makers. The research shows that enterprise networks are expanding and becoming more distributed, increasing demand for reliability,...
04 Aug 2026 | Global | Market Research
Global Capnography Devices Market, Forecast to 2031
The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aiswariya Chidambaram |
| WIP Number | MA1E-01-00-00-00 |
| Is Prebook | No |